<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?OLF?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Rev Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Nat. Rev. Immunol</journal-id><journal-title-group><journal-title>Nature Reviews. Immunology</journal-title></journal-title-group><issn pub-type="ppub">1474-1733</issn><issn pub-type="epub">1474-1741</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7288618</article-id><article-id pub-id-type="publisher-id">348</article-id><article-id pub-id-type="doi">10.1038/s41577-020-0348-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Considering how biological sex impacts immune responses and COVID-19 outcomes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Scully</surname><given-names>Eileen P.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Haverfield</surname><given-names>Jenna</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3398-331X</contrib-id><name><surname>Ursin</surname><given-names>Rebecca L.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Tannenbaum</surname><given-names>Cara</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Klein</surname><given-names>Sabra L.</given-names></name><address><email>sklein2@jhu.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>Division of Infectious Diseases, Department of Medicine, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">000000010789659X</institution-id><institution-id institution-id-type="GRID">grid.248883.d</institution-id><institution>Institute of Gender and Health, </institution><institution>Canadian Institutes of Health Research, </institution></institution-wrap>Montr&#x000e9;al, Qu&#x000e9;bec Canada </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>Department of Biochemistry and Molecular Biology, </institution><institution>The Johns Hopkins Bloomberg School of Public Health, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2292 3357</institution-id><institution-id institution-id-type="GRID">grid.14848.31</institution-id><institution>Centre de Recherche de l&#x02019;Institut Universitaire de G&#x000e9;riatrie de Montr&#x000e9;al, Facult&#x000e9; de M&#x000e9;decine, </institution><institution>Universit&#x000e9; de Montr&#x000e9;al, </institution></institution-wrap>Montr&#x000e9;al, Qu&#x000e9;bec Canada </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>W. Harry Feinstone Department of Molecular Microbiology and Immunology, </institution><institution>The Johns Hopkins Bloomberg School of Public Health, </institution></institution-wrap>Baltimore, MD USA </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>6</month><year>2020</year></pub-date><fpage>1</fpage><lpage>6</lpage><history><date date-type="accepted"><day>20</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; Springer Nature Limited 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">A male bias in mortality has emerged in the COVID-19 pandemic, which is consistent with the pathogenesis of other viral infections. Biological sex differences may manifest themselves in susceptibility to infection, early pathogenesis, innate viral control, adaptive immune responses or the balance of inflammation and tissue repair in the resolution of infection. We discuss available sex-disaggregated epidemiological data from the COVID-19 pandemic, introduce sex-differential features of immunity and highlight potential sex differences underlying COVID-19 severity. We propose that sex differences in immunopathogenesis will inform mechanisms of COVID-19, identify points for therapeutic intervention and improve vaccine design and increase vaccine efficacy.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">Why are males more susceptible to severe COVID-19 than females? In this Perspective, Sabra Klein and colleagues consider the sex differences in the immune system that may contribute to this sex bias.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Immunogenetics</kwd><kwd>SARS-CoV-2</kwd></kwd-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">The COVID-19 pandemic, caused by the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of infections and hundreds of thousands of deaths worldwide. Human biological sex plays a fundamental role in heterogeneous COVID-19 outcomes. Sex, defined as male, female or intersex on the basis of sex chromosome complement, reproductive tissues (ovaries or testes) and sex steroid hormone (oestrogen, progesterone and testosterone) concentrations, is a multidimensional biological characteristic that shapes infectious disease pathogenesis. We discuss how sex differences in basic molecular and cellular mechanisms can be leveraged to define the immune response to infection with SARS-CoV-2.</p></sec><sec id="Sec2"><title>Sex differences in COVID-19 severity</title><p id="Par4">The precise drivers of death, regardless of sex, in COVID-19 remain unknown. There appears to be a subset of patients in whom high levels of dysregulated inflammation lead to severe multisystem organ pathology<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. A postviral inflammatory syndrome has also emerged in children with COVID-19 (refs<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>). As a result, research on therapeutics has focused on both antiviral and immunomodulatory pathways<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup> with the goal of achieving an optimized balance in immune response induction and resolution. Unfortunately, most studies fail to consider the sex of the patients, which may mask therapeutic targets.</p><p id="Par5">Evidence of sex differences in COVID-19 severity emerged in China, where hospital admissions and mortality were higher among males than females<sup><xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref></sup>. In South Korea, where community testing was widespread, females represented ~60% of those testing positive for SARS-CoV-2, suggesting that females acquire infection, despite having a lower case fatality rate (CFR)<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. In the United States, where testing was prioritized for people with symptomatic disease, the diagnosis rates were similar in males and females, but males had 1.5 times higher mortality<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par6">A male bias in COVID-19 mortality is currently reported in 37 of the 38 countries that have provided sex-disaggregated data (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). Our analyses show that the average male CFR across 38 countries is 1.7&#x000a0;times higher than the average female CFR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) (male CFR 7.3 (95% CI 5.4&#x02013;9.2); female CFR 4.4 (95% CI 3.4&#x02013;5.5)), which is consistent with other reports<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. There is increased risk of death for both sexes with advancing age, but at all ages above 30 years males have a significantly higher risk of death than females (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). A male predominance of deaths from COVID-19 is consistent with what was observed in the prior SARS<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup> and Middle East respiratory syndrome (MERS)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> epidemics (caused by SARS-CoV and MERS-CoV, respectively). Although gender-related social factors, including smoking, health care-seeking behaviours and some co-morbid conditions, may impact the outcomes of COVID-19 (refs<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>) and contribute to male&#x02013;female differences in disease severity, the cross-cultural emergence of increased risk of death for males points to biological risk determinants. In animal models of SARS-CoV infection, differences in mortality between male and female mice were observed and were attributed to steroid hormones<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Multiple dimensions of biological sex, including sex steroids, sex chromosomes and genomic and epigenetic differences between males and females, impact immune responses<sup><xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref></sup> and may affect responses to SARS-CoV-2 infection<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.<fig id="Fig1"><label>Fig. 1</label><caption><title>Comparative analyses of COVID-19 case fatality rates by country, sex and age.</title><p><bold>a</bold> | COVID-19 case fatality rates (CFRs) for males and females across 38 countries or regions reporting sex-disaggregated data on COVID-19 cases and deaths. CFR was calculated as the total number of deaths divided by the total number of cases for each sex multiplied by 100. The male CFR is higher than the female CFR in 37 of the 38 regions, with an average male CFR 1.7 times greater than the average female CFR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001, Wilcoxon signed rank test). <bold>b</bold> | Average COVID-19 CFRs for males and females stratified by age. The data represent 12 countries currently reporting sex- and age-disaggregated data on COVID-19 cases and deaths (Australia, Columbia, Denmark, Italy, Mexico, Norway, Pakistan, Philippines, Portugal, Spain, Switzerland and England). The COVID-19 CFR increases for both sexes with advancing age, but males have a significantly higher CFR than females at all ages from 30 years (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, Wilcoxon signed rank test). The data were obtained from <ext-link ext-link-type="uri" xlink:href="http://globalhealth5050.org/covid19/">Global Health 50/50</ext-link> and official government websites of each respective country on 7 May and 8 May 2020. For more information on the data source for a specific country, please contact the corresponding author.</p></caption><graphic xlink:href="41577_2020_348_Fig1_HTML" id="d30e364"/></fig></p></sec><sec id="Sec3"><title>Ageing, sex and COVID-19</title><p id="Par7">Although advancing age is associated with greater risk of death in both sexes, the male bias remains evident (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). An analysis of COVID-19 data from Italy, Spain, Germany, Switzerland, Belgium and Norway reveals that among all age groups older than 20 years, fatality rates are greater for males than females<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. By contrast, male&#x02013;female differences in the rate of confirmed SARS-CoV-2 infections are age dependent in all countries, being greater among females aged between 10 and 50 years and greater among males before the age of 10 years and after the age of 50 years<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. The age-related male&#x02013;female differences in confirmed cases of SARS-CoV-2 infections are consistent with reported confirmed cases of seasonal and pandemic influenza A virus infections in Australia and Japan<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. We interpret these data to suggest that biological sex differences contribute to male-biased death, but gender-associated risk of exposure may affect rates of infection differently for males and females.</p><p id="Par8">With a focus on biology, the impact of age on susceptibility to severe COVID-19 needs to be parsed, with both immunosenescence and dysregulation of innate immune responses as potential mechanisms<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. Biological sex differentially affects ageing of the immune system<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, in part through changing concentrations of sex steroids<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. In addition to reduced concentrations of sex steroids, an age-related mosaic loss of chromosome Y in leukocytes can alter transcriptional regulation of immunoregulatory genes<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Whether sex differences in the genomic signatures of aged immune cells translate to functional differences in the response to SARS-CoV-2 infection requires attention.</p></sec><sec id="Sec4"><title>Sex differences in immune responses</title><p id="Par9">Biological sex affects innate and adaptive immune responses to self and foreign antigens, resulting in sex differences in autoimmunity as well as in responses to infections and vaccines<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Immune cell subsets have sex-specific patterns of gene expression, with most differentially expressed genes found on autosomes, demonstrating sex-specific regulation of shared genetic material<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The sex chromosomes also directly contribute. Males are at higher risk of diseases caused by deleterious X-linked alleles. Incomplete inactivation of immunoregulatory genes on the X chromosome can also occur in females, which results in a gene dosage imbalance between sexes<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>. Incomplete X chromosome inactivation has been implicated in female-biased autoimmune diseases<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> and in vaccine efficacy<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. The Y chromosome has immunoregulatory function, broadly impacting immune transcriptional profiles linked to autoimmune disease<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> and impacting outcomes of influenza virus and coxsackie virus infection in animals<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. Sex-specific features of epigenomic organization also dictate differential availability of transcriptional targets<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. Superimposed on these genomic elements is the direct effect of sex steroid exposure. Oestrogens<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>, progesterone<sup><xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref></sup> and testosterone<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> have direct effects on immune cell function that are driven by the signalling of these hormones through their respective cellular receptors. The variation in sex steroid concentrations that occurs over the life course contributes to differences in immune profiles and disease susceptibility patterns at different ages<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. Consistent with this variation, both sex and age contribute to unique transcriptional signatures of immune cells both at the baseline and after exposure to immunostimulants<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. The summative effect is a sex-specific transcriptional regulatory network of genetic variants, epigenetic modifications, transcription factors and sex steroids that leads to a functional difference in the immune response<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> highlights intersections between SARS-CoV-2 infection and sources of sex bias in pathophysiology that warrant further investigation.<fig id="Fig2"><label>Fig. 2</label><caption><title>Known sex differences that may impact immune responses to SARS-CoV-2 and COVID-19 progression.</title><p>An illustrative summary of the sequence of events in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the associated immune responses. Broadly speaking (from left to right), there are the initial steps of virus entry, innate recognition of the virus with activation of antiviral programmes, the recruitment of innate immune cells and induction of an adaptive immune response. These major steps culminate either in successful control of infection and pathogen elimination or in a pathological inflammatory state. Sex differences that may be operative at multiple points along these pathways are indicated in the blue boxes. ACE2, angiotensin-converting enzyme 2; H1N1, H1N1 influenza virus; IFN&#x003b1;, interferon-&#x003b1;; NK, natural killer; pDC, plasmacytoid dendritic cell; TLR7, Toll-like receptor 7; TMPRSS2, transmembrane protease serine 2.</p></caption><graphic xlink:href="41577_2020_348_Fig2_HTML" id="d30e515"/></fig></p></sec><sec id="Sec5"><title>Sex bias in SARS-CoV-2 infection</title><sec id="Sec6"><title>Virus entry receptors</title><p id="Par10">SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as an entry receptor, with virus entry enhanced by cellular transmembrane serine protease 2 (TMPRSS2), which primes the spike protein of the virus<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. <italic>ACE2</italic> is an X chromosome-encoded gene that is downregulated by oestrogens<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> and exhibits tissue-specific expression patterns<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Differences in <italic>ACE2</italic>&#x000a0;expression may be driven by sex-differential expression of <italic>ACE2</italic> variants<sup><xref ref-type="bibr" rid="CR58">58</xref>&#x02013;<xref ref-type="bibr" rid="CR60">60</xref></sup>. ACE2 is associated with interferon gene expression<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>, which in turn shows sex-specific regulation. The cell-intrinsic regulation of ACE2 expression may change with age, in response to changing levels of sex steroids, or following viral challenge. TMPRSS2 is regulated by androgen receptor signalling in prostate cells<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Initial investigations have not demonstrated a significant difference in <italic>TMPRSS2</italic> mRNA expression in lung tissue from males and females, but it is unknown whether androgens may impact expression in the setting of infection with SARS-CoV-2 (refs<sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup>) or whether the level of expression has an impact on SARS-CoV-2 burden. Further research is needed to determine whether sex-biased expression of <italic>ACE2</italic>, coupled with the regulation of <italic>TMPRSS2</italic> by androgens, increases SARS-CoV-2 susceptibility of males compared with females.</p></sec><sec id="Sec7"><title>Interferons</title><p id="Par11">Innate sensing of viruses, production of interferons and activation of the inflammasome are the first line of defence against viruses<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. In the case of SARS-CoV-2, where there is no pre-existing adaptive immune memory, the&#x000a0;success&#x000a0;of this early antiviral response may be a determinant of disease outcome. Innate sensing of viral RNA by the pattern-recognition receptor Toll-like receptor 7 (TLR7) is sex biased, as <italic>TLR7</italic> escapes X chromosome inactivation, resulting in greater expression in female immune cells; this has also been linked to sex differences in autoimmunity<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup> and vaccine efficacy<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. There is greater production of interferon-&#x003b1; (IFN&#x003b1;) from plasmacytoid dendritic cells from adult females than from adult males<sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>, an effect modulated by sex steroids<sup><xref ref-type="bibr" rid="CR69">69</xref>&#x02013;<xref ref-type="bibr" rid="CR71">71</xref></sup>. In animal models of SARS-CoV infection, pretreatment with pegylated IFN&#x003b1; was associated with protection of lung tissue<sup><xref ref-type="bibr" rid="CR72">72</xref></sup> but without consideration of biological sex. In SARS-CoV-2, emerging data suggest that there is aberrant activation of interferon responses but preserved chemokine signalling, which has been postulated to contribute to immunopathology<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Studies are needed to determine whether differences in the magnitude or kinetics of the interferon response may contribute to a sex bias in the early control or severity of SARS-CoV-2 infection and may inform considerations of interferons as therapies for COVID-19 (ref.<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>). Early data suggest that male sex may be associated with a longer duration of viral detection, even within families<sup><xref ref-type="bibr" rid="CR75">75</xref>,<xref ref-type="bibr" rid="CR76">76</xref></sup>, raising the question of whether females have more efficient clearance of the virus. The rate of virus clearance will need to be assessed in evaluating the efficacy of innate and adaptive immune responses.</p></sec><sec id="Sec8"><title>Adaptive immunity</title><p id="Par12">Females generally mount greater antibody responses to viral infection and vaccination, albeit with higher levels of autoreactivity<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. The mechanisms for sex differences in antibody production include oestrogenic enhancement of somatic hypermutation<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>, less stringent selection against autoreactive B cells<sup><xref ref-type="bibr" rid="CR77">77</xref>,<xref ref-type="bibr" rid="CR79">79</xref>&#x02013;<xref ref-type="bibr" rid="CR82">82</xref></sup> and sex differences in germinal centre formation<sup><xref ref-type="bibr" rid="CR83">83</xref></sup> and in the epigenetic accessibility of B cell loci<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. It is still unknown whether sex has an impact on antibody generation in SARS-CoV-2 infection. Early studies suggest that titres of antibodies to some viral epitopes are higher in patients with severe COVID-19 and that seroconversion may not be tightly linked to declining virus titres<sup><xref ref-type="bibr" rid="CR84">84</xref>,<xref ref-type="bibr" rid="CR85">85</xref></sup>. Ongoing studies evaluating the infusion of convalescent serum may provide answers as to the protective capacity of these antibodies<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>, but these studies are currently not considering biological sex. Generation of protective, neutralizing antibodies is a goal of vaccine development, with the cautionary note that in models of SARS-CoV vaccination some antibody responses induced potent inflammatory responses<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. Persistence of antibodies, epitope targeting and non-neutralizing Fc-mediated antibody characteristics should be assessed with sex-stratified analyses. As vaccines are developed, the female bias towards both potent responses and adverse effects should be considered and sex-specific dosing should be tested, where appropriate<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>.</p><p id="Par13">Sex impacts the development of regulatory T cells<sup><xref ref-type="bibr" rid="CR88">88</xref>&#x02013;<xref ref-type="bibr" rid="CR91">91</xref></sup>, the distribution of lymphocyte subsets<sup><xref ref-type="bibr" rid="CR92">92</xref></sup> and the overall quality of T cell responses<sup><xref ref-type="bibr" rid="CR93">93</xref>,<xref ref-type="bibr" rid="CR94">94</xref></sup>. In T cells, overexpression of X-encoded immune genes, including <italic>CD40L</italic><italic>G</italic> and <italic>CXCR3</italic>, has been linked to incomplete X chromosome inactivation and T cell-specific epigenetic modifications of the X chromosome<sup><xref ref-type="bibr" rid="CR95">95</xref>,<xref ref-type="bibr" rid="CR96">96</xref></sup>. It is unknown whether T cell phenotypes contribute to COVID-19; data from the prior SARS outbreak did not link T cell responses to outcomes in humans<sup><xref ref-type="bibr" rid="CR97">97</xref></sup>, but mouse models suggest a role for CD4<sup>+</sup> T cells<sup><xref ref-type="bibr" rid="CR98">98</xref></sup>. In patients with MERS, T cell responses were dysregulated<sup><xref ref-type="bibr" rid="CR99">99</xref></sup>, but sex differences were not analysed. In the current pandemic, lymphopenia is associated with severe disease<sup><xref ref-type="bibr" rid="CR100">100</xref>,<xref ref-type="bibr" rid="CR101">101</xref></sup>, and early evidence suggests that the clinical markers of lymphocyte count may be lower in males and neutrophil&#x02013;lymphocyte ratios may be higher<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Further work is needed to define the sex-differential role of T cells in acute infection, in acute lung injury phenotypes<sup><xref ref-type="bibr" rid="CR102">102</xref></sup> and as potential vaccine targets.</p></sec><sec id="Sec9"><title>Severe infection and acute respiratory distress syndrome</title><p id="Par14">Severe cases of COVID-19 are typically marked by acute respiratory distress syndrome (ARDS), with respiratory failure requiring oxygen support and mechanical ventilation. The infection is primarily characterized by diffuse alveolar damage without a consistent pattern of cell infiltration<sup><xref ref-type="bibr" rid="CR75">75</xref>,<xref ref-type="bibr" rid="CR103">103</xref>&#x02013;<xref ref-type="bibr" rid="CR105">105</xref></sup>. The pathogenesis of ARDS involves the disruption of normal barrier function, inflammation and subsequent tissue repair. Whether there are sex-specific risks for ARDS and death from other causes, such as trauma, remains unknown<sup><xref ref-type="bibr" rid="CR106">106</xref>,<xref ref-type="bibr" rid="CR107">107</xref></sup>, although there is a suggestion of a higher risk of lower respiratory tract infections among males<sup><xref ref-type="bibr" rid="CR108">108</xref></sup> and that steroid hormones modulate the immune response to respiratory viral pathogens<sup><xref ref-type="bibr" rid="CR109">109</xref></sup>. In one cohort of patients with COVID-19, severe respiratory failure was associated with a pattern of inflammation, macrophage activation and depletion of lymphocytes that was distinct from bacterial infection<sup><xref ref-type="bibr" rid="CR110">110</xref></sup>. There was a sex bias for severe COVID-19 not observed in the comparator group with bacterial infections<sup><xref ref-type="bibr" rid="CR110">110</xref></sup>. Sex-differential production of IL-6 (ref.<sup><xref ref-type="bibr" rid="CR111">111</xref></sup>), monocyte transcriptional patterns and inflammatory set point<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup> could contribute to an enhanced risk of death in males and highlight the importance of sex-stratified analyses to guide deployment of safe and effective immunomodulatory therapeutics for males and females<sup><xref ref-type="bibr" rid="CR112">112</xref></sup>.</p></sec></sec><sec id="Sec10" sec-type="conclusion"><title>Conclusions</title><p id="Par15">Emerging data demonstrating&#x000a0;more favourable outcomes for community-dwelling adult females across age strata offer an immediate opportunity for comparative biology experiments to define features of COVID-19 pathogenesis and the associated immune response. The research pipeline should integrate sex as a biological variable in all stages, from fundamental research to preclinical drug development, clinical trials and epidemiological analyses<sup><xref ref-type="bibr" rid="CR113">113</xref></sup>. Considering the role of intersecting factors &#x02014; including, but not limited to, gender, age, race and other identifying characteristics &#x02014; is critical to understanding the biological and sociocultural factors contributing to heterogeneous COVID-19 outcomes. Sex is a driver of discovery and innovation<sup><xref ref-type="bibr" rid="CR114">114</xref></sup>, and taking a sex-informed approach to COVID-19 research<sup><xref ref-type="bibr" rid="CR115">115</xref></sup> and medicine<sup><xref ref-type="bibr" rid="CR116">116</xref></sup> will uncover novel features of the host immune response to SARS-CoV-2 and ultimately result in more equitable health outcomes.</p></sec></body><back><fn-group><fn><p><bold>Peer review information</bold></p><p><italic>Nature Reviews Immunology</italic> thanks E. Fish, P. McCombe and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.</p></fn><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p><bold>Related links</bold></p><p><bold>Global Health 50/50</bold>: <ext-link ext-link-type="uri" xlink:href="http://globalhealth5050.org/covid19/">http://globalhealth5050.org/covid19/</ext-link></p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>The authors contributed equally to all aspects of the article.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par16">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P</given-names></name><etal/></person-group><article-title>COVID-19: consider cytokine storm syndromes and immunosuppression</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>1033</fpage><lpage>1034</lpage><?supplied-pmid 32192578?><pub-id pub-id-type="pmid">32192578</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlin</surname><given-names>DA</given-names></name><name><surname>Gulick</surname><given-names>RM</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name></person-group><article-title>Severe Covid-19</article-title><source>N. Engl. J. Med.</source><year>2020</year><pub-id pub-id-type="doi">10.1056/NEJMcp2009575</pub-id><?supplied-pmid 32412710?><pub-id pub-id-type="pmid">32412710</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdoni</surname><given-names>L</given-names></name><etal/></person-group><article-title>An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>1771</fpage><lpage>1778</lpage><?supplied-pmid 32410760?><pub-id pub-id-type="pmid">32410760</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). <italic>CDC</italic><ext-link ext-link-type="uri" xlink:href="https://emergency.cdc.gov/han/2020/han00432.asp">https://emergency.cdc.gov/han/2020/han00432.asp</ext-link> (2020).</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vabret</surname><given-names>N</given-names></name><etal/></person-group><article-title>Immunology of COVID-19: current state of the science</article-title><source>Immunity</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.immuni.2020.05.002</pub-id><?supplied-pmid 32505227?><pub-id pub-id-type="pmid">32505227</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><etal/></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>507</fpage><lpage>513</lpage><?supplied-pmid 32007143?><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title><source>N. Engl. J. Med.</source><year>2020</year><volume>382</volume><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="pmid">32109013</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>McGoogan</surname><given-names>JM</given-names></name></person-group><article-title>Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention</article-title><source>JAMA</source><year>2020</year><pub-id pub-id-type="doi">10.1001/jama.2020.2648</pub-id><?supplied-pmid 32515813?><pub-id pub-id-type="pmid">32515813</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>JP</given-names></name><name><surname>Lee</surname><given-names>NT</given-names></name></person-group><article-title>Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea</article-title><source>Clin. Infect. Dis.</source><year>2020</year><pub-id pub-id-type="doi">10.1093/cid/ciaa354</pub-id><?supplied-pmid 32232322?><pub-id pub-id-type="pmid">32232322</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Ministry of Health and Welfare of South Korea. Domestic occurrence status. <italic>MOHW</italic><ext-link ext-link-type="uri" xlink:href="http://ncov.mohw.go.kr/bdBoardList_Real.do?brdId=1&#x00026;brdGubun=11&#x00026;ncvContSeq=&#x00026;contSeq=&#x00026;board_id=&#x00026;gubun=">http://ncov.mohw.go.kr/bdBoardList_Real.do?brdId=1&#x00026;brdGubun=11&#x00026;ncvContSeq=&#x00026;contSeq=&#x00026;board_id=&#x00026;gubun=</ext-link> (2020).</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">NYC. COVID-19: data. <italic>NYC.gov</italic><ext-link ext-link-type="uri" xlink:href="https://www1.nyc.gov/site/doh/covid/covid-19-data.page">https://www1.nyc.gov/site/doh/covid/covid-19-data.page</ext-link> (2020).</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J-M</given-names></name><etal/></person-group><article-title>Gender differences in patients with COVID-19: focus on severity and mortality</article-title><source>Front. Public Health</source><year>2020</year><pub-id pub-id-type="doi">10.3389/fpubh.2020.00152</pub-id><?supplied-pmid 32411652?><pub-id pub-id-type="pmid">32411652</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Peckham, H. et al. Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity. Preprint at <italic>ResearchSquare</italic>10.21203/rs.3.rs-23651/v2 (2020).</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlberg</surname><given-names>J</given-names></name><name><surname>Chong</surname><given-names>DS</given-names></name><name><surname>Lai</surname><given-names>WY</given-names></name></person-group><article-title>Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?</article-title><source>Am. J. Epidemiol.</source><year>2004</year><volume>159</volume><fpage>229</fpage><lpage>231</lpage><?supplied-pmid 14742282?><pub-id pub-id-type="pmid">14742282</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>HN</given-names></name><etal/></person-group><article-title>SARS in Singapore&#x02013;predictors of disease severity</article-title><source>Ann. Acad. Med. Singap.</source><year>2006</year><volume>35</volume><fpage>326</fpage><lpage>331</lpage><?supplied-pmid 16829999?><pub-id pub-id-type="pmid">16829999</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alghamdi</surname><given-names>IG</given-names></name><etal/></person-group><article-title>The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health</article-title><source>Int. J. Gen. Med.</source><year>2014</year><volume>7</volume><fpage>417</fpage><lpage>423</lpage><?supplied-pmid 25187734?><pub-id pub-id-type="pmid">25187734</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients</article-title><source>PLOS Pathog.</source><year>2020</year><volume>16</volume><fpage>e1008520</fpage><?supplied-pmid 32343745?><pub-id pub-id-type="pmid">32343745</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Channappanavar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>4046</fpage><lpage>53.</lpage><?supplied-pmid 28373583?><pub-id pub-id-type="pmid">28373583</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongen</surname><given-names>E</given-names></name><etal/></person-group><article-title>Sex differences in the blood transcriptome identify robust changes in immune cell proportions with aging and influenza infection</article-title><source>Cell Rep.</source><year>2019</year><volume>29</volume><fpage>1961</fpage><lpage>73 e4</lpage><?supplied-pmid 31722210?><pub-id pub-id-type="pmid">31722210</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Klein</surname><given-names>RS</given-names></name></person-group><article-title>Sex drives dimorphic immune responses to viral infections</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>1782</fpage><lpage>90.</lpage><?supplied-pmid 28223406?><pub-id pub-id-type="pmid">28223406</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquez</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Sexual-dimorphism in human immune system aging</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>751</fpage><?supplied-pmid 32029736?><pub-id pub-id-type="pmid">32029736</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piasecka</surname><given-names>B</given-names></name><etal/></person-group><article-title>Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>E488</fpage><lpage>E497.</lpage><?supplied-pmid 29282317?><pub-id pub-id-type="pmid">29282317</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurz</surname><given-names>H</given-names></name><etal/></person-group><article-title>The X chromosome and sex-specific effects in infectious disease susceptibility</article-title><source>Hum. Genomics</source><year>2019</year><volume>13</volume><fpage>2</fpage><?supplied-pmid 30621780?><pub-id pub-id-type="pmid">30621780</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>vom Steeg</surname><given-names>LG</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>SeXX matters in infectious disease pathogenesis</article-title><source>PLoS Pathog.</source><year>2016</year><volume>12</volume><fpage>e1005374</fpage><?supplied-pmid 26891052?><pub-id pub-id-type="pmid">26891052</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ober</surname><given-names>C</given-names></name><name><surname>Loisel</surname><given-names>DA</given-names></name><name><surname>Gilad</surname><given-names>Y</given-names></name></person-group><article-title>Sex-specific genetic architecture of human disease</article-title><source>Nat. Rev. Genet.</source><year>2008</year><volume>9</volume><fpage>911</fpage><lpage>922</lpage><?supplied-pmid 19002143?><pub-id pub-id-type="pmid">19002143</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmiedel</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Impact of genetic polymorphisms on human immune cell gene expression</article-title><source>Cell</source><year>2018</year><volume>175</volume><fpage>1701</fpage><lpage>15.e16</lpage><?supplied-pmid 30449622?><pub-id pub-id-type="pmid">30449622</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Klein, S. L. et al. Biological sex impacts COVID-19 outcomes in the United States. <italic>PLoS Pathog</italic>. (in the press).</mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Marina S. &#x00026; Piemonti L. Gender and age effects on the rates of infection and deaths in individuals with confirmed SARS-CoV-2 infection in six European countries. <italic>Lancet</italic>10.2139/ssrn.3576790 (2020).</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>KC</given-names></name><name><surname>Luscombe</surname><given-names>GM</given-names></name><name><surname>Hawke</surname><given-names>C</given-names></name></person-group><article-title>Influenza infections in Australia 2009&#x02013;2015: is there a combined effect of age and sex on susceptibility to virus subtypes?</article-title><source>BMC Infect. Dis.</source><year>2019</year><volume>19</volume><fpage>42</fpage><?supplied-pmid 30630435?><pub-id pub-id-type="pmid">30630435</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshima</surname><given-names>N</given-names></name><etal/></person-group><article-title>Sex- and age-related differences in morbidity rates of 2009 pandemic influenza A H1N1 virus of swine origin in Japan</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e19409</fpage><?supplied-pmid 21559366?><pub-id pub-id-type="pmid">21559366</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koff</surname><given-names>WC</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name></person-group><article-title>Covid-19 and immunity in aging populations &#x02014; a new research agenda</article-title><source>N. Engl. J. Med.</source><year>2020</year><pub-id pub-id-type="doi">10.1056/NEJMp2006761</pub-id><?supplied-pmid 32302079?><pub-id pub-id-type="pmid">32302079</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name><etal/></person-group><article-title>SARS-COV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes</article-title><source>GeroScience</source><year>2020</year><volume>42</volume><fpage>505</fpage><lpage>514</lpage><?supplied-pmid 32274617?><pub-id pub-id-type="pmid">32274617</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>SX</given-names></name><name><surname>Margolick</surname><given-names>JB</given-names></name></person-group><article-title>Aging, sex, inflammation, frailty, and CMV and HIV infections</article-title><source>Cell Immunol.</source><year>2020</year><volume>348</volume><fpage>104024</fpage><?supplied-pmid 31843200?><pub-id pub-id-type="pmid">31843200</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potluri</surname><given-names>T</given-names></name><etal/></person-group><article-title>Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females</article-title><source>NPJ Vaccines</source><year>2019</year><volume>4</volume><fpage>29</fpage><?supplied-pmid 31312529?><pub-id pub-id-type="pmid">31312529</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Dumanski, J. P. et al. Immune cells lacking Y chromosome have widespread dysregulation of autosomal genes. Preprint at <italic>bioRxiv</italic>10.1101/673459 (2020).</mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>SL</given-names></name><name><surname>Flanagan</surname><given-names>KL</given-names></name></person-group><article-title>Sex differences in immune responses</article-title><source>Nat. Rev. Immunol.</source><year>2016</year><volume>16</volume><fpage>626</fpage><lpage>638</lpage><?supplied-pmid 27546235?><pub-id pub-id-type="pmid">27546235</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markle</surname><given-names>JG</given-names></name><name><surname>Fish</surname><given-names>EN</given-names></name></person-group><article-title>SeXX matters in immunity</article-title><source>Trends Immunol.</source><year>2014</year><volume>35</volume><fpage>97</fpage><lpage>104</lpage><?supplied-pmid 24239225?><pub-id pub-id-type="pmid">24239225</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrel</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>CJ</given-names></name></person-group><article-title>When the Lyon(ized chromosome) roars: ongoing expression from an inactive X chromosome</article-title><source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source><year>2017</year><volume>372</volume><fpage>20160355</fpage><?supplied-pmid 28947654?><pub-id pub-id-type="pmid">28947654</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukiainen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Landscape of X chromosome inactivation across human tissues</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>244</fpage><lpage>248</lpage><?supplied-pmid 29022598?><pub-id pub-id-type="pmid">29022598</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souyris</surname><given-names>M</given-names></name><etal/></person-group><article-title>TLR7 escapes X chromosome inactivation in immune cells</article-title><source>Sci. Immunol.</source><year>2018</year><volume>3</volume><fpage>eaap8855</fpage><?supplied-pmid 29374079?><pub-id pub-id-type="pmid">29374079</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>AL</given-names></name><name><surname>Engle</surname><given-names>K</given-names></name><name><surname>Ursin</surname><given-names>RL</given-names></name><name><surname>Tang</surname><given-names>WY</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>Biological sex affects vaccine efficacy and protection against influenza in mice</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>12477</fpage><lpage>82.</lpage><?supplied-pmid 30455317?><pub-id pub-id-type="pmid">30455317</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Case</surname><given-names>LK</given-names></name><etal/></person-group><article-title>The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease</article-title><source>Genome Res.</source><year>2013</year><volume>23</volume><fpage>1474</fpage><lpage>1485</lpage><?supplied-pmid 23800453?><pub-id pub-id-type="pmid">23800453</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krementsov</surname><given-names>DN</given-names></name><etal/></person-group><article-title>Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>3491</fpage><lpage>3496</lpage><?supplied-pmid 28242695?><pub-id pub-id-type="pmid">28242695</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>DP</given-names></name><etal/></person-group><article-title>Sex chromosome complement contributes to sex differences in Coxsackievirus B3 but not influenza A virus pathogenesis</article-title><source>Biol. Sex. Differ.</source><year>2011</year><volume>2</volume><fpage>8</fpage><?supplied-pmid 21806829?><pub-id pub-id-type="pmid">21806829</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>26779</fpage><lpage>26787</lpage></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straub</surname><given-names>RH</given-names></name></person-group><article-title>The complex role of estrogens in inflammation</article-title><source>Endocr. Rev.</source><year>2007</year><volume>28</volume><fpage>521</fpage><lpage>574</lpage><?supplied-pmid 17640948?><pub-id pub-id-type="pmid">17640948</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peretz</surname><given-names>J</given-names></name><name><surname>Pekosz</surname><given-names>A</given-names></name><name><surname>Lane</surname><given-names>AP</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors</article-title><source>Am. J. Physiol. Lung Cell Mol. Physiol</source><year>2016</year><volume>310</volume><fpage>L415</fpage><lpage>L425</lpage><?supplied-pmid 26684252?><pub-id pub-id-type="pmid">26684252</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>OJ</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites</article-title><source>Mucosal Immunol.</source><year>2017</year><volume>10</volume><fpage>1097</fpage><lpage>107.</lpage><?supplied-pmid 28401937?><pub-id pub-id-type="pmid">28401937</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Progesterone-based therapy protects against influenza by promoting lung repair and recovery in females</article-title><source>PLoS Pathog.</source><year>2016</year><volume>12</volume><fpage>e1005840</fpage><?supplied-pmid 27631986?><pub-id pub-id-type="pmid">27631986</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Progesterone-based contraceptives reduce adaptive immune responses and protection against sequential influenza A virus infections</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><fpage>e02160-16</fpage><?supplied-pmid 28179523?><pub-id pub-id-type="pmid">28179523</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vom Steeg</surname><given-names>LG</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>Sex steroids mediate bidirectional interactions between hosts and microbes</article-title><source>Horm. Behav.</source><year>2017</year><volume>88</volume><fpage>45</fpage><lpage>51</lpage><?supplied-pmid 27816626?><pub-id pub-id-type="pmid">27816626</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vom Steeg</surname><given-names>LG</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>Sex and sex steroids impact influenza pathogenesis across the life course</article-title><source>Semin. Immunopathol.</source><year>2019</year><volume>41</volume><fpage>189</fpage><lpage>94.</lpage><?supplied-pmid 30298431?><pub-id pub-id-type="pmid">30298431</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>869</fpage><lpage>874</lpage><?supplied-pmid 24367114?><pub-id pub-id-type="pmid">24367114</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellegren</surname><given-names>H</given-names></name><name><surname>Parsch</surname><given-names>J</given-names></name></person-group><article-title>The evolution of sex-biased genes and sex-biased gene expression</article-title><source>Nat. Rev. Genet.</source><year>2007</year><volume>8</volume><fpage>689</fpage><lpage>698</lpage><?supplied-pmid 17680007?><pub-id pub-id-type="pmid">17680007</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M</given-names></name><etal/></person-group><article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>271</fpage><lpage>280</lpage><?supplied-pmid 32142651?><pub-id pub-id-type="pmid">32142651</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuyama</surname><given-names>S</given-names></name><etal/></person-group><article-title>Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>7001</fpage><lpage>7003</lpage><?supplied-pmid 32165541?><pub-id pub-id-type="pmid">32165541</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17beta-oestradiol-dependent and sex chromosome-independent</article-title><source>Biol. Sex. Differ.</source><year>2010</year><volume>1</volume><fpage>6</fpage><?supplied-pmid 21208466?><pub-id pub-id-type="pmid">21208466</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender: a case-control study</article-title><source>Medicine</source><year>2018</year><volume>97</volume><fpage>e12917</fpage><?supplied-pmid 30335025?><pub-id pub-id-type="pmid">30335025</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Asselta, R., Paraboschi, E. M., Mantovani, A. &#x00026; Duga, S. <italic>ACE2</italic> and <italic>TMPRSS2</italic> variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Preprint at <italic>medRxiv</italic>10.1101/2020.03.30.20047878 (2020).</mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Gibson, W. T., Evans, D. M., An, J. &#x00026; Jones, S. J. ACE 2 coding variants: a potential x-linked risk factor for COVID-19 disease. Preprint at <italic>bioRxiv</italic>10.1101/2020.04.05.026633 (2020).</mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues. <italic>Cell</italic><bold>181</bold>, 1016&#x02013;1035 (2020).</mixed-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungnak</surname><given-names>W</given-names></name><etal/></person-group><article-title>SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title><source>Nat. Med.</source><year>2020</year><volume>26</volume><fpage>681</fpage><lpage>687</lpage><?supplied-pmid 32327758?><pub-id pub-id-type="pmid">32327758</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stopsack</surname><given-names>KH</given-names></name><name><surname>Mucci</surname><given-names>LA</given-names></name><name><surname>Antonarakis</surname><given-names>ES</given-names></name><name><surname>Nelson</surname><given-names>PS</given-names></name><name><surname>Kantoff</surname><given-names>PW</given-names></name></person-group><article-title><italic>TMPRSS2</italic> and COVID-19: serendipity or opportunity for intervention?</article-title><source>Cancer Discov.</source><year>2020</year><pub-id pub-id-type="doi">10.1158/2159-8290.CD-20-0451</pub-id><?supplied-pmid 32276929?><pub-id pub-id-type="pmid">32276929</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Baratchian, M. et al. No evidence that androgen regulation of pulmonary TMPRSS2 explains sex-discordant COVID-19 outcomes. Preprint at <italic>bioRxiv</italic>10.1101/2020.04.21.051201 (2020).</mixed-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><article-title>A virological view of innate immune recognition</article-title><source>Annu. Rev. Microbiol.</source><year>2012</year><volume>66</volume><fpage>177</fpage><lpage>196</lpage><?supplied-pmid 22994491?><pub-id pub-id-type="pmid">22994491</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souyris</surname><given-names>M</given-names></name><name><surname>Mejia</surname><given-names>JE</given-names></name><name><surname>Chaumeil</surname><given-names>J</given-names></name><name><surname>Guery</surname><given-names>JC</given-names></name></person-group><article-title>Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation</article-title><source>Semin. Immunopathol.</source><year>2019</year><volume>41</volume><fpage>153</fpage><lpage>64.</lpage><?supplied-pmid 30276444?><pub-id pub-id-type="pmid">30276444</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berghofer</surname><given-names>B</given-names></name><etal/></person-group><article-title>TLR7 ligands induce higher IFN-alpha production in females</article-title><source>J. Immunol.</source><year>2006</year><volume>177</volume><fpage>2088</fpage><lpage>2096</lpage><?supplied-pmid 16887967?><pub-id pub-id-type="pmid">16887967</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1</article-title><source>Nat. Med.</source><year>2009</year><volume>15</volume><fpage>955</fpage><lpage>959</lpage><?supplied-pmid 19597505?><pub-id pub-id-type="pmid">19597505</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griesbeck</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-alpha production in women</article-title><source>J. Immunol.</source><year>2015</year><volume>195</volume><fpage>5327</fpage><lpage>5336</lpage><?supplied-pmid 26519527?><pub-id pub-id-type="pmid">26519527</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laffont</surname><given-names>S</given-names></name><etal/></person-group><article-title>X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-alpha production of plasmacytoid dendritic cells from women</article-title><source>J. Immunol.</source><year>2014</year><volume>193</volume><fpage>5444</fpage><lpage>5452</lpage><?supplied-pmid 25339659?><pub-id pub-id-type="pmid">25339659</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seillet</surname><given-names>C</given-names></name><etal/></person-group><article-title>The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>454</fpage><lpage>464</lpage><?supplied-pmid 22096248?><pub-id pub-id-type="pmid">22096248</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haagmans</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques</article-title><source>Nat. Med.</source><year>2004</year><volume>10</volume><fpage>290</fpage><lpage>293</lpage><?supplied-pmid 14981511?><pub-id pub-id-type="pmid">14981511</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">Blanco-Melo, D. N.-P. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. <italic>Cell</italic>10.1016/j.cell.2020.04.026 (2020).</mixed-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sallard</surname><given-names>E</given-names></name><name><surname>Lescure</surname><given-names>FX</given-names></name><name><surname>Yazdanpanah</surname><given-names>Y</given-names></name><name><surname>Mentre</surname><given-names>F</given-names></name><name><surname>Peiffer-Smadja</surname><given-names>N</given-names></name></person-group><article-title>Type 1 interferons as a potential treatment against COVID-19</article-title><source>Antivir. Res.</source><year>2020</year><volume>178</volume><fpage>104791</fpage><?supplied-pmid 32275914?><pub-id pub-id-type="pmid">32275914</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">Xu, K. et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. <italic>Clin. Infect. Dis.</italic>10.1093/cid/ciaa351 (2020).</mixed-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S</given-names></name><etal/></person-group><article-title>Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study</article-title><source>BMJ</source><year>2020</year><volume>369</volume><fpage>m1443</fpage><?supplied-pmid 32317267?><pub-id pub-id-type="pmid">32317267</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakiani</surname><given-names>S</given-names></name><name><surname>Olsen</surname><given-names>NJ</given-names></name><name><surname>Kovacs</surname><given-names>WJ</given-names></name></person-group><article-title>Gonadal steroids and humoral immunity</article-title><source>Nat. Rev. Endocrinol.</source><year>2013</year><volume>9</volume><fpage>56</fpage><lpage>62</lpage><?supplied-pmid 23183675?><pub-id pub-id-type="pmid">23183675</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauklin</surname><given-names>S</given-names></name><name><surname>Sernandez</surname><given-names>IV</given-names></name><name><surname>Bachmann</surname><given-names>G</given-names></name><name><surname>Ramiro</surname><given-names>AR</given-names></name><name><surname>Petersen-Mahrt</surname><given-names>SK</given-names></name></person-group><article-title>Estrogen directly activates AID transcription and function</article-title><source>J. Exp. Med.</source><year>2009</year><volume>206</volume><fpage>99</fpage><lpage>111</lpage><?supplied-pmid 19139166?><pub-id pub-id-type="pmid">19139166</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bynoe</surname><given-names>MS</given-names></name><name><surname>Grimaldi</surname><given-names>CM</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name></person-group><article-title>Estrogen up-regulates Bcl-2 and blocks tolerance induction of na&#x000ef;ve B cells</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>2703</fpage><lpage>2708</lpage><?supplied-pmid 10694576?><pub-id pub-id-type="pmid">10694576</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>CM</given-names></name><name><surname>Cleary</surname><given-names>J</given-names></name><name><surname>Dagtas</surname><given-names>AS</given-names></name><name><surname>Moussai</surname><given-names>D</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name></person-group><article-title>Estrogen alters thresholds for B cell apoptosis and activation</article-title><source>J. Clin. Invest.</source><year>2002</year><volume>109</volume><fpage>1625</fpage><lpage>1633</lpage><?supplied-pmid 12070310?><pub-id pub-id-type="pmid">12070310</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>CM</given-names></name><name><surname>Jeganathan</surname><given-names>V</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name></person-group><article-title>Hormonal regulation of B cell development: 17&#x003b2;-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint</article-title><source>J. Immunol.</source><year>2006</year><volume>176</volume><fpage>2703</fpage><lpage>2710</lpage><?supplied-pmid 16493025?><pub-id pub-id-type="pmid">16493025</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>L</given-names></name><name><surname>Jeganathan</surname><given-names>V</given-names></name><name><surname>Chinnasamy</surname><given-names>P</given-names></name><name><surname>Grimaldi</surname><given-names>C</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name></person-group><article-title>Differential roles of estrogen receptors &#x003b1; and &#x003b2; in control of B-cell maturation and selection</article-title><source>Mol. Med.</source><year>2011</year><volume>17</volume><fpage>211</fpage><lpage>220</lpage><?supplied-pmid 21107497?><pub-id pub-id-type="pmid">21107497</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>R</given-names></name><etal/></person-group><article-title>A GPR174-CCL21 module imparts sexual dimorphism to humoral immunity</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>416</fpage><lpage>20.</lpage><?supplied-pmid 31875850?><pub-id pub-id-type="pmid">31875850</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study</article-title><source>Lancet Infect. Dis.</source><year>2020</year><volume>20</volume><fpage>565</fpage><lpage>74.</lpage><?supplied-pmid 32213337?><pub-id pub-id-type="pmid">32213337</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="other">Wolfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. <italic>Nature</italic>10.1038/s41586-020-2196-x (2020).</mixed-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Treatment of 5 critically ill patients with COVID-19 with convalescent plasma</article-title><source>JAMA</source><year>2020</year><volume>323</volume><fpage>1582</fpage><lpage>1589</lpage></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanagan</surname><given-names>KL</given-names></name><name><surname>Fink</surname><given-names>AL</given-names></name><name><surname>Plebanski</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>Sex and gender differences in the outcomes of vaccination over the life course</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2017</year><volume>33</volume><fpage>577</fpage><lpage>99.</lpage><?supplied-pmid 28992436?><pub-id pub-id-type="pmid">28992436</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragin</surname><given-names>N</given-names></name><etal/></person-group><article-title>Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases</article-title><source>J. Clin. Invest.</source><year>2016</year><volume>126</volume><fpage>1525</fpage><lpage>1537</lpage><?supplied-pmid 26999605?><pub-id pub-id-type="pmid">26999605</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polanczyk</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment</article-title><source>J. Immunol.</source><year>2004</year><volume>173</volume><fpage>2227</fpage><lpage>2230</lpage><?supplied-pmid 15294932?><pub-id pub-id-type="pmid">15294932</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>P</given-names></name><etal/></person-group><article-title>Induction of regulatory T cells by physiological level estrogen</article-title><source>J. Cell Physiol.</source><year>2008</year><volume>214</volume><fpage>456</fpage><lpage>464</lpage><?supplied-pmid 17654501?><pub-id pub-id-type="pmid">17654501</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator</article-title><source>Nat. Commun.</source><year>2016</year><volume>7</volume><fpage>11350</fpage><?supplied-pmid 27072778?><pub-id pub-id-type="pmid">27072778</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>ST</given-names></name><etal/></person-group><article-title>Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites</article-title><source>Am. J. Physiol. Endocrinol. Metab.</source><year>2006</year><volume>290</volume><fpage>E856</fpage><lpage>E863</lpage><?supplied-pmid 16352669?><pub-id pub-id-type="pmid">16352669</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewagama</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>D</given-names></name><name><surname>Yarlagadda</surname><given-names>S</given-names></name><name><surname>Strickland</surname><given-names>FM</given-names></name><name><surname>Richardson</surname><given-names>BC</given-names></name></person-group><article-title>Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis</article-title><source>Genes. Immun.</source><year>2009</year><volume>10</volume><fpage>509</fpage><lpage>516</lpage><?supplied-pmid 19279650?><pub-id pub-id-type="pmid">19279650</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yee Mon</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Differential sensitivity to IL-12 drives sex-specific differences in the CD8+ T cell response to infection</article-title><source>Immunohorizons</source><year>2019</year><volume>3</volume><fpage>121</fpage><lpage>132</lpage><?supplied-pmid 31317126?><pub-id pub-id-type="pmid">31317126</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Individuality and variation of personal regulomes in primary human T cells</article-title><source>Cell Syst.</source><year>2015</year><volume>1</volume><fpage>51</fpage><lpage>61</lpage><?supplied-pmid 26251845?><pub-id pub-id-type="pmid">26251845</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>E2029</fpage><lpage>E2038</lpage><?supplied-pmid 27001848?><pub-id pub-id-type="pmid">27001848</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janice Oh</surname><given-names>HL</given-names></name><name><surname>Ken-En Gan</surname><given-names>S</given-names></name><name><surname>Bertoletti</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>YJ</given-names></name></person-group><article-title>Understanding the T cell immune response in SARS coronavirus infection</article-title><source>Emerg. Microbes Infect.</source><year>2012</year><volume>1</volume><fpage>e23</fpage><?supplied-pmid 26038429?><pub-id pub-id-type="pmid">26038429</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>1289</fpage><lpage>1301</lpage><?supplied-pmid 19906920?><pub-id pub-id-type="pmid">19906920</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alosaimi</surname><given-names>B</given-names></name><etal/></person-group><article-title>MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract</article-title><source>Cytokine</source><year>2020</year><volume>126</volume><fpage>154895</fpage><?supplied-pmid 31706200?><pub-id pub-id-type="pmid">31706200</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title><source>Intensive Care Med.</source><year>2020</year><volume>46</volume><fpage>846</fpage><lpage>848</lpage><?supplied-pmid 32125452?><pub-id pub-id-type="pmid">32125452</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</article-title><source>Lancet Respir. Med.</source><year>2020</year><volume>8</volume><fpage>475</fpage><lpage>481.</lpage><?supplied-pmid 32105632?><pub-id pub-id-type="pmid">32105632</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halter</surname><given-names>S</given-names></name><etal/></person-group><article-title>T regulatory cells activation and distribution are modified in critically ill patients with acute respiratory distress syndrome: a prospective single-centre observational study</article-title><source>Anaesth. Crit. Care Pain. Med.</source><year>2020</year><volume>39</volume><fpage>35</fpage><lpage>44</lpage><?supplied-pmid 31374365?><pub-id pub-id-type="pmid">31374365</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>LM</given-names></name><name><surname>Duval</surname><given-names>EJ</given-names></name><name><surname>Stroberg</surname><given-names>E</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name></person-group><article-title>COVID-19 autopsies, Oklahoma, USA</article-title><source>Am. J. Clin. Pathol.</source><year>2020</year><volume>153</volume><fpage>725</fpage><lpage>33.</lpage><?supplied-pmid 32275742?><pub-id pub-id-type="pmid">32275742</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer</article-title><source>J. Thorac. Oncol.</source><year>2020</year><volume>15</volume><fpage>700</fpage><lpage>704</lpage><?supplied-pmid 32114094?><pub-id pub-id-type="pmid">32114094</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="other">Tian, S. et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. <italic>Mod. Pathol.</italic>10.1038/s41379-020-0536-x (2020).</mixed-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heffernan</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Gender and acute respiratory distress syndrome in critically injured adults: a prospective study</article-title><source>J. Trauma</source><year>2011</year><volume>71</volume><fpage>878</fpage><lpage>883</lpage><?supplied-pmid 21986736?><pub-id pub-id-type="pmid">21986736</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><etal/></person-group><article-title>The influence of sex on outcomes in trauma patients: a meta-analysis</article-title><source>Am. J. Surg.</source><year>2015</year><volume>210</volume><fpage>911</fpage><lpage>921</lpage><?supplied-pmid 26145388?><pub-id pub-id-type="pmid">26145388</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname><given-names>ME</given-names></name><name><surname>Mourtzoukou</surname><given-names>EG</given-names></name><name><surname>Vardakas</surname><given-names>KZ</given-names></name></person-group><article-title>Sex differences in the incidence and severity of respiratory tract infections</article-title><source>Respir. Med.</source><year>2007</year><volume>101</volume><fpage>1845</fpage><lpage>1863</lpage><?supplied-pmid 17544265?><pub-id pub-id-type="pmid">17544265</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>DP</given-names></name><name><surname>Hall</surname><given-names>OJ</given-names></name><name><surname>Nilles</surname><given-names>TL</given-names></name><name><surname>Bream</surname><given-names>JH</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name></person-group><article-title>17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>4711</fpage><lpage>4720</lpage><?supplied-pmid 24522912?><pub-id pub-id-type="pmid">24522912</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="other">Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. <italic>Cell Host Microbe</italic>10.1016/j.chom.2020.04.009 (2020).</mixed-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naugler</surname><given-names>WE</given-names></name><etal/></person-group><article-title>Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>121</fpage><lpage>124</lpage><?supplied-pmid 17615358?><pub-id pub-id-type="pmid">17615358</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="other">Bischof, E., Wolfe, J. &#x00026; Klein, S. L. Clinical trials for COVID-19 should include sex as a variable. <italic>J. Clin. Invest.</italic>10.1172/JCI139306 (2020).</mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="other">Canadian Institutes of Health Research. Why sex and gender need to be considered in COVID-19 research. <italic>CIHR</italic><ext-link ext-link-type="uri" xlink:href="https://cihr-irsc.gc.ca/e/51939.html">https://cihr-irsc.gc.ca/e/51939.html</ext-link> (2020).</mixed-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Opinion: sex inclusion in basic research drives discovery</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>5257</fpage><lpage>5258</lpage><?supplied-pmid 25902532?><pub-id pub-id-type="pmid">25902532</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tannenbaum</surname><given-names>C</given-names></name><name><surname>Ellis</surname><given-names>RP</given-names></name><name><surname>Eyssel</surname><given-names>F</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Schiebinger</surname><given-names>L</given-names></name></person-group><article-title>Sex and gender analysis improves science and engineering</article-title><source>Nature</source><year>2019</year><volume>575</volume><fpage>137</fpage><lpage>46.</lpage><?supplied-pmid 31695204?><pub-id pub-id-type="pmid">31695204</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartz</surname><given-names>D</given-names></name><etal/></person-group><article-title>Clinical advances in sex- and gender-informed medicine to improve the health of all: a review</article-title><source>JAMA Intern. Med.</source><year>2020</year><volume>180</volume><fpage>574</fpage><lpage>583</lpage></element-citation></ref></ref-list></back></article>